Abeona Therapeutics Inc

NASDAQ:ABEO

5.10

+0.07 (+1.39%)

4:45:34 PM EDT: $5.06 -0.04 (-0.78%)

Market Cap (Intraday)	208.91M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.13 Million
Adjusted EPS	-$0.33

See more estimates

10-Day MA	$5.07
50-Day MA	$4.60
200-Day MA	$5.27

See more pivots

Abeona Therapeutics Inc Stock, NASDAQ:ABEO

6555 Carnegie Avenue, 4th floor, Cleveland, Ohio 44103

United States of America

Phone: +1.646.813.4701

Number of Employees: 84

http://www.abeonatherapeutics.com

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.